Markets

Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE939A01011 | SECTOR: PharmaceuticalsPharmaceuticals

Success

Alert

Please select a Day.

Info

TTrade Now TTrade Now

Strides Pharma | BSE 469.65 -25.95 (-5.24%) | NSE 470.15 -25.60 (-5.16%) | TTrade Now | Add

BSE Live

Feb 28, 16:00

469.65 -25.95 (-5.24%)

Volume

AVERAGE VOLUME

5-Day

102,293

10-Day

103,477

30-Day

195,544

86,378

Prev. Close

495.60
Open Price

485.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Feb 28, 15:50

470.15 -25.60 (-5.16%)

Volume

AVERAGE VOLUME

5-Day

315,887

10-Day

446,499

30-Day

940,112

289,520

Prev. Close

495.75
Open Price

483.10

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
470.15 (501)

Financials

Download Annual Report in PDF format 2019 2018 2017 2016 2015

Print/Copy to Excel : Go

Balance Sheet of Strides Pharma Science (in Rs. Cr.)	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	89.55	89.50	89.42	89.35	59.62
Total Share Capital	89.55	89.50	89.42	89.35	59.62
Reserves and Surplus	3,167.25	3,072.37	3,143.10	3,046.06	1,414.81
Total Reserves and Surplus	3,167.25	3,072.37	3,143.10	3,046.06	1,414.81
Total Shareholders Funds	3,256.80	3,161.87	3,232.53	3,135.41	1,474.42
NON-CURRENT LIABILITIES
Long Term Borrowings	0.15	2.45	769.45	880.70	164.25
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	33.62	0.00
Other Long Term Liabilities	3.98	3.33	22.52	14.99	12.59
Long Term Provisions	12.88	13.32	22.58	10.14	16.86
Total Non-Current Liabilities	17.01	19.10	814.56	939.45	193.70
CURRENT LIABILITIES
Short Term Borrowings	808.80	601.59	647.44	544.41	162.66
Trade Payables	509.40	390.72	470.56	497.17	188.62
Other Current Liabilities	49.49	84.90	290.28	195.69	103.39
Short Term Provisions	21.31	26.84	25.87	51.87	41.01
Total Current Liabilities	1,388.99	1,104.05	1,434.16	1,289.13	495.68
Total Capital And Liabilities	4,662.80	4,285.16	5,481.24	5,363.99	2,163.80
ASSETS
NON-CURRENT ASSETS
Tangible Assets	444.59	432.51	837.87	781.73	330.30
Intangible Assets	52.14	65.45	285.90	277.11	64.20
Capital Work-In-Progress	72.56	86.89	99.63	126.42	21.07
Other Assets	76.88	66.00	70.07	0.00	0.00
Fixed Assets	696.07	707.81	1,351.58	1,238.92	433.60
Non-Current Investments	1,994.59	1,465.19	1,240.70	1,233.92	407.17
Deferred Tax Assets [Net]	80.12	53.51	19.34	0.00	1.76
Long Term Loans And Advances	91.61	37.49	54.81	230.26	104.63
Other Non-Current Assets	136.82	521.61	235.65	1.90	1.27
Total Non-Current Assets	2,999.21	2,785.62	2,902.08	2,704.99	948.43
CURRENT ASSETS
Current Investments	154.29	311.48	1,279.54	1,132.95	561.29
Inventories	473.34	269.63	409.53	379.23	155.40
Trade Receivables	582.56	449.37	540.69	702.30	256.01
Cash And Cash Equivalents	180.81	79.79	94.92	94.34	74.30
Short Term Loans And Advances	27.60	26.23	8.65	326.16	102.12
OtherCurrentAssets	244.99	363.05	245.84	24.03	66.25
Total Current Assets	1,663.59	1,499.54	2,579.16	2,659.01	1,215.37
Total Assets	4,662.80	4,285.16	5,481.24	5,363.99	2,163.80
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	5,766.31	4,437.15	5,478.48	5,370.32	3,869.40
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	406.52	246.08
Stores, Spares And Loose Tools	0.00	0.00	0.00	11.98	7.83
Trade/Other Goods	0.00	0.00	0.00	11.98	7.83
Capital Goods	0.00	0.00	0.00	37.96	26.94
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	39.50	71.02	0.00	72.75	35.68
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	0.04	0.88
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	1,519.23	720.43
Other Earnings	1,462.98	1,569.71	--	141.95	582.63
BONUS DETAILS
Bonus Equity Share Capital	1.25	1.25	1.25	1.25	1.25
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	--	0.11	1,240.70	1,233.92	407.17
CURRENT INVESTMENTS
Current Investments Quoted Market Value	154.29	311.48	1,279.54	--	--
Current Investments Unquoted Book Value	--	--	--	1,132.95	561.29